FDA says J&J’s coronavirus vaccine is safe and effective, paving way to approval
WASHINGTON (AP) — An analysis by U.S. regulators says Johnson & Johnson’s single-dose vaccine provides strong protection against severe COVID-19.
The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19.
On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot.
The FDA is expected to make a final decision within days.
If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away.
Only a few million doses are expected to be ready for shipping in the first week.
Johnson & Johnson said they have four million doses ready to be shipped as soon as possible and Dr. Wilma Wooten said she is optimistic about this increasing our doses in San Diego County.
KUSI’s Hunter Sowards joined viewers live from downtown with more.